Background:: This study assessed the effect of a systemic oral treatment with antioxidants (AOs) in preretinopathic diabetes (PRD) patients, through the evaluation of oxidative stress in plasma and changes in the full-field electroretinogram (ERG). Methods: Thirty-two PRD subjects with good metabolic control were recruited. Patients were randomized in two groups, one of which received oral AO treatment with alpha-lipoic acid at 400 mg/day in association with genistein and vitamins, whereas the other group received a placebo. Free radicals and the AO barrier were evaluated in plasma with the Free Radical Analytical System 4 instrument (H&D srl, Parma, Italy), and the same day the electrophysiological response was measured by ERG. These analyses were performed at enrollment and after 30 days of treatment. Results: Statistically significant increases of plasma AO levels and ERG oscillatory potential values were observed in the group treated with AO, but not in the control group. Conclusions: Results of this preliminary study suggest that an oral treatment with AOs in PRD subjects may have a protective effect on retinal cells, as detected by ERG analysis, through the strengthening of the plasma AO barrier.

Oxidative stress in pre-retinopathic diabetic subjects and antioxidants / Nebbioso, Marcella; M., Federici; D., Rusciano; M., Evangelista; Pescosolido, Nicola. - In: DIABETES TECHNOLOGY & THERAPEUTICS. - ISSN 1520-9156. - STAMPA. - 14:3(2012), pp. 257-263. [10.1089/dia.2011.0172]

Oxidative stress in pre-retinopathic diabetic subjects and antioxidants

NEBBIOSO, Marcella
Primo
Writing – Review & Editing
;
PESCOSOLIDO, Nicola
2012

Abstract

Background:: This study assessed the effect of a systemic oral treatment with antioxidants (AOs) in preretinopathic diabetes (PRD) patients, through the evaluation of oxidative stress in plasma and changes in the full-field electroretinogram (ERG). Methods: Thirty-two PRD subjects with good metabolic control were recruited. Patients were randomized in two groups, one of which received oral AO treatment with alpha-lipoic acid at 400 mg/day in association with genistein and vitamins, whereas the other group received a placebo. Free radicals and the AO barrier were evaluated in plasma with the Free Radical Analytical System 4 instrument (H&D srl, Parma, Italy), and the same day the electrophysiological response was measured by ERG. These analyses were performed at enrollment and after 30 days of treatment. Results: Statistically significant increases of plasma AO levels and ERG oscillatory potential values were observed in the group treated with AO, but not in the control group. Conclusions: Results of this preliminary study suggest that an oral treatment with AOs in PRD subjects may have a protective effect on retinal cells, as detected by ERG analysis, through the strengthening of the plasma AO barrier.
2012
antioxidants (AOs); oxidative stress; preretinopathic diabetes (PRD)
01 Pubblicazione su rivista::01l Trial clinico
Oxidative stress in pre-retinopathic diabetic subjects and antioxidants / Nebbioso, Marcella; M., Federici; D., Rusciano; M., Evangelista; Pescosolido, Nicola. - In: DIABETES TECHNOLOGY & THERAPEUTICS. - ISSN 1520-9156. - STAMPA. - 14:3(2012), pp. 257-263. [10.1089/dia.2011.0172]
File allegati a questo prodotto
File Dimensione Formato  
Nebbioso_Oxidative_2012.pdf

solo gestori archivio

Note: https://www.liebertpub.com/doi/abs/10.1089/dia.2011.0172?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=dia
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 309.82 kB
Formato Adobe PDF
309.82 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/439314
Citazioni
  • ???jsp.display-item.citation.pmc??? 24
  • Scopus 44
  • ???jsp.display-item.citation.isi??? 42
social impact